The resultant IgE/FcεRI pathway activation promotes MC degranulation and the release of bioactive mediators and inflammatory factors, such histamine, interleukin (IL)-6, and IL-13, which mediate allergic reactions [3,4,5]. Here, MS4A2 is linked to allergic disease.